Authors: de Gast, GC Klumpen, HJ Vyth-Dreese, FA Kersten, MJ Verra, NCV Sein, J Batchelor, D Nooijen, WJ Schornagel, JH

Citation: Gc. De Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma, CLIN CANC R, 6(4), 2000, pp. 1267-1272